跳转至内容
Merck
所有图片(3)

文件

N3915

Sigma-Aldrich

三七皂苷R1

≥98% (HPLC)

别名:

(3β,6α,12β)-20-(β-D-葡糖基核糖氧基)-3,12-二羟基达玛-24-en-6-yl 2-O-β-D-木吡喃糖基-β-D-吡喃葡萄糖苷, 人参皂苷R1

登录查看公司和协议定价
所有图片(3)

About This Item

经验公式（希尔记法）:
C47H80O18
CAS号:
80418-24-2
分子量:
933.13
MDL號碼:
MFCD00210535
分類程式碼代碼:
12352205
PubChem物質ID:
329818642
NACRES:
NA.25

生物源

Panax notoginseng (Burk.) F.H.Chen

化驗

≥98% (HPLC)

形狀

powder

顏色

white to off-white

溶解度

H2O: 1 mg/mL, clear, colorless

應用

metabolomics
vitamins, nutraceuticals, and natural products

儲存溫度

2-8°C

SMILES 字串

C\C(C)=C\CC[C@](C)(O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)[C@H]2CC[C@]3(C)[C@@H]2[C@H](O)C[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5[C@H](C[C@@]34C)O[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O[C@@H]7OC[C@@H](O)[C@H](O)[C@H]7O

InChI

1S/C47H80O18/c1-21(2)10-9-13-47(8,65-41-37(59)34(56)32(54)26(18-48)62-41)22-11-15-45(6)30(22)23(50)16-28-44(5)14-12-29(52)43(3,4)39(44)25(17-46(28,45)7)61-42-38(35(57)33(55)27(19-49)63-42)64-40-36(58)31(53)24(51)20-60-40/h10,22-42,48-59H,9,11-20H2,1-8H3/t22-,23+,24+,25-,26+,27+,28+,29-,30-,31-,32+,33+,34-,35-,36+,37+,38+,39-,40-,41-,42+,44+,45+,46+,47-/m0/s1

InChI 密鑰

LLPWNQMSUYAGQI-OOSPGMBYSA-N

正在寻找类似产品? 访问 产品对比指南

相关类别

生化／生理作用

三七皂苷R1已显示出具有抗氧化剂、抗炎、抗凋亡和免疫刺激特性。

象形圖

Exclamation mark
GHS07

訊號詞

Warning

危險聲明

H302

危險分類

Acute Tox. 4 Oral

儲存類別代碼

11 - Combustible Solids

水污染物質分類（WGK）

WGK 3

閃點（°F）

Not applicable

閃點（°C）

Not applicable

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ （Lot或Batch）字后找到。

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

其他客户在看

Slide 1 of 2

1 of 2

人参皂甙 Rb2 analytical standard

Supelco

41868

人参皂甙 Rb2

人参皂苷 Rg3 ≥98% (HPLC)

Sigma-Aldrich

SML0184

人参皂苷 Rg3

ZhiGuo Yu et al.
Chemical & pharmaceutical bulletin, 54(4), 588-590 (2006-04-06)
A high-performance liquid chromatograph with mass spectrum detection (HPLC-MS/APCI) method has been established for simultaneous determination of ten major bioactive components of Naodesheng injection including safflor yellow A, puerarin, daidzein, ginsenosides (Rg1, Rg2, Rb1, Rd, Re, Rh1), and notoginsenoside R1.
Hong-Sheng Zhang et al.
Vascular pharmacology, 44(4), 224-230 (2006-02-07)
Notoginsenoside R1 is the main ingredient with cardiovascular activity in Panax notoginseng. We reported that notoginsenoside R1 significantly decreased tumor necrosis factor-alpha (TNF-alpha)-induced plasminogen activator inhibitor-1 (PAI-1) mRNA, protein level and secretion in human aortic smooth muscle cells (HASMCs) in
Chong Li et al.
American journal of physiology. Gastrointestinal and liver physiology, 306(2), G111-G122 (2013-11-16)
Intestinal ischemia and reperfusion (I/R) is a clinical problem occurred for diverse causes with high mortality. Prophylaxis and treatment of intestinal I/R remains a challenge for clinicians. The purpose of the present study was to explore the role of Notoginsenoside
J B Wan et al.
Journal of pharmaceutical and biomedical analysis, 41(1), 274-279 (2005-12-01)
A HPLC and pressurized liquid extraction (PLE) method was developed for simultaneous determination of nine saponins, including notoginsenoside R1, ginsenoside Rg1, Re, Rf, Rb1, Rc, Rb2, Rb3 and Rd in Panax notoginseng. The analysis was performed on C18 column with
Jian-Qing Ruan et al.
Journal of agricultural and food chemistry, 58(9), 5770-5776 (2010-04-22)
As a main and characteristic constituent in Radix notoginseng, the fate of notoginsenoside R1 (NGR1) in human is largely unknown. The present study investigated, for the first time, NGR1 metabolism by human intestinal bacteria and liver subcellular fractions, and permeability
查看所有相关文献

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门